Together, these data demonstrate that efficient knockdown of neutrophil STAT3 via the intratumoral injection of CpG-Stat3ASO supported the expansion of potently cytotoxic CD8+ T cells and therefore provides a promising strategy for cancer immunotherapy. The gene discussed is STAT3; the disease is cancer.